Ethical Overview of Pharmaceutical Industry Policies in Turkey from Various Perspectives.

Objectives: Countries' national drug policies include all key stakeholders (pharmacists, physicians, pharmaceutical firms, and patients) in the public, the private sector, and the field of pharmacy. The aim of this study was to outline pharmaceutical patents and data protection, orphan drugs, drug pricing, and surplus goods regarding pharmacoeconomics, promotions, inspections in the pharmaceutical industry, and policies in pharmacies with respect to buying and selling drugs, and to discuss ethics in particular.

Materials And Methods: Written laws in force relating to drugs in Turkey constitute the materials of this study.

A Qualitative Evaluation of Ethics Educational Program in Health Science.

This paper originates from a panel discussion on the evaluation of "Ethics Educational Program in Health Sciences" held during the IAEE Conference 2014 Ankara, Turkey. The participants of the panel had consultations to solidify the concepts about the topic. The qualitative data out of these antecedent discussions became mature with the contributions in the panel.

A QUALITATIVE EVALUATION OF ETHICS EDUCATIONAL PROGRAM IN HEALTH SCIENCE.

This paper originates from a panel discussion on the evaluation of the "Ethics Educational Program in Health Sciences" held during the JAEE Conference 2014 Ankara, Turkey. Prior to the panel's discussion, its participants held consultations aimed at solidifying the concepts of the topic. The qualitative data gathered at these consultations matured through the panel members' contribution to the IAEE discussion.